Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.

Abstract

Lysophosphatidic acid (LPA) is a bioactive lipid mediator of inflammation via the LPA receptors 1-6. We and others have previously described proinflammatory and profibrotic activities of LPA signaling in bleomycin- or lipopolysaccharide (LPS)-induced pulmonary fibrosis or lung injury models. In this study, we investigated if LPA signaling plays a role in the pathogenesis of systemic sepsis from an abdominal source. We report here that antagonism of the LPA receptor LPA1 with the small molecule ki16425 reduces the severity of abdominal inflammation and organ damage in the setting of peritoneal endotoxin exposure. Pretreatment of mice with intraperitoneal ki16425 eliminates LPS-induced peritoneal neutrophil chemokine and cytokine production, liver oxidative stress, liver injury, and cellular apoptosis in visceral organs. Mice pretreated with ki16425 are also protected from LPS-induced mortality. Tissue myeloperoxidase activity is not affected by LPA1 antagonism. We have shown that LPA1 is associated with LPS coreceptor CD14 and the association is suppressed by ki16425. LPS-induced phosphorylation of protein kinase C δ (PKCδ) and p38 mitogen-activated protein kinase (p38 MAPK) in liver cells and interleukin 6 production in Raw264 cells are likewise blunted by LPA1 antagonism. These studies indicate that the small molecule inhibitor of LPA1, ki16425, suppresses cytokine responses and inflammation in a peritoneal sepsis model by blunting downstream signaling through the LPA1-CD14-toll-like receptor 4 receptor complex. This anti-inflammatory effect may represent a therapeutic strategy for the treatment of systemic inflammatory responses to infection of the abdominal cavity.

• Authors: Jing Zhao, Jianxin Wei, Nathaniel Weathington, Anastasia M Jacko, Hai Huang, Allan Tsung, Yutong Zhao
• Journal: Translational research : the journal of laboratory and clinical medicine (Transl Res) Vol. 166 Issue 1 Pg. 80-8 (Jul 2015) ISSN: 1878-1810 [Electronic] United States
• PMID: 25701366 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• 3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid
• Cytokines
• Isoxazoles
• Lipopolysaccharide Receptors
• Lipopolysaccharides
• Propionates
• Receptors, Lysophosphatidic Acid
• Peroxidase
• Alanine Transaminase

Topics

• Alanine Transaminase (blood)
• Animals
• Apoptosis (drug effects)
• Cell Line
• Cytokines (biosynthesis)
• Disease Models, Animal
• HEK293 Cells
• Hep G2 Cells
• Humans
• Isoxazoles (pharmacology)
• Lipopolysaccharide Receptors (metabolism)
• Lipopolysaccharides (toxicity)
• Liver (drug effects, metabolism, pathology)
• Male
• Mice
• Mice, Inbred C57BL
• Peritonitis (metabolism, pathology, prevention & control)
• Peroxidase (metabolism)
• Propionates (pharmacology)
• Receptors, Lysophosphatidic Acid (antagonists & inhibitors, metabolism)
• Sepsis (metabolism, pathology, prevention & control)
• Signal Transduction (drug effects)
• Translational Research, Biomedical